BFC Planning’s BridgeBio Pharma BBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7.24K Buy
110
+42
+62% +$3.27K ﹤0.01% 2529
2026
Q2
$5.06K Buy
68
+25
+58% +$1.75K ﹤0.01% 2676
2026
Q1
$3.2K Buy
43
+29
+207% +$2.1K ﹤0.01% 2472
2025
Q4
$1.07K Buy
+14
New +$919 ﹤0.01% 2775

Other funds holding BBIO

BFC Planning's BBIO Position: Q3 2026 in Review

BFC Planning increased its BridgeBio Pharma (BBIO) stake by 62% in Q3 2026, buying an estimated $3.27K and bringing the position to 110 shares worth $7.24K. The position accounts for ﹤0.01% of the portfolio, ranked #2529.

BFC Planning first reported a position in BBIO in Q4 2025 and has held it in 4 quarters since. 354 funds tracked by Wall St. Rank hold BBIO as of Q3 2026.

  • BFC Planning held 110 shares of BridgeBio Pharma worth $7.24K as of Q3 2026.
  • BFC Planning bought 42 BridgeBio Pharma shares in Q3 2026, an estimated $3.27K.
  • BridgeBio Pharma made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #2529 holding.
  • BFC Planning first reported a position in BridgeBio Pharma in Q4 2025 and has held it in 4 quarters since.
  • 354 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.